Geneos Wealth Management Inc. Mustang Bio, Inc. Transaction History

Geneos Wealth Management Inc.

  • $2.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$0.58 - $1.13 $377 - $734
-650 Closed
0 $0
Q4 2020

May 19, 2021
SELL
$2.66 - $4.18 $6,974 - $10,959
-2,622 Reduced 80.13%
650 $2,000
Q1 2019

Sep 07, 2021
BUY
$2.95 - $5.61 $9,652 - $18,355
3,272 New
3,272 $11,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $20M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email